Han publicado los resultados positivos del ensayo clínico APRIL de Fase 1b/2a de aptaTargets, que ha evaluado la seguridad y eficacia del innovador fármaco neuroprotector ApTOLL en combinación con ...
Read moreUn estudio liderado por el CIBER (Centro de Investigación Biomédica en Red) y el Instituto de Investigación Biomédica de Girona Dr. Josep Trueta (IDIBGI) vincula directamente la comida ultra-proce...
Read moreInvestigadores del área de enfermedades hepáticas y digestivas del CIBER (CIBEREHD) han participado en el desarrollo de un innovador dispositivo de diálisis hepática para la insuficiencia hepátic...
Read moreUn estudio realizado por el Grupo de Fisiopatología Vascular y el Grupo de Neurocríticos del IBiS y del Hospital Universitario Virgen del Rocío descubre que las lipoproteínas de alta densidad (HDL...
Read moreHan correlacionado los valores medios diarios de vitamina D con la evolución del índice UV máximo diario y la temperatura media ambiental, demostrando, tras cinco años de medidas en Málaga, que e...
Read moreThe “MucOncoBots” project has a primary objective of employing nanobots to transport a specialized drug for the treatment of peritoneal pseudomyxoma (PMP). This rare disease is distinguished by th...
Read moreLed by researchers from Clínic-IDIBAPS with support from Fundació "la Caixa", the study shows that pregnant women who follow a Mediterranean diet have between 25% and 28% less anxiety, better wellbe...
Read moreMaternal obesity during pregnancy is known to be associated with an increased risk of chronic diseases in the offspring. Epigenetic mechanisms (those that regulate gene expression), such as DNA methyl...
Read moreA device that combines microfluidics on paper, electrochemical transduction and immunoassays on magnetic nanoparticles is able to detect biomarkers of inflammation in sputum samples, useful for easy a...
Read morePeptomyc has received full study approval for its Phase Ib clinical trial evaluating the combination of its first-in-class MYC inhibitor Omomyc (OMO-103) with standard of care in metastatic pancreatic...
Read moreAelis Farma announced publication of a series of studies describing a new pharmacological class, cannabinoid receptor 1 signaling-specific inhibitors (CB1-SSi), and its first drug candidate, AEF0117, ...
Read moreThe study, led by researchers from Clínic-IDIBAPS and CIBER, reveals new functions of TCF20, beyond its role in neurologic processes and its implication in neurologic disorders.
Read more